Detalhe da pesquisa
1.
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
N Engl J Med
; 388(1): 44-54, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546659
2.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(18): 1672-1684, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870974
3.
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation.
N Engl J Med
; 387(2): 120-131, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658005
4.
Sotorasib for Lung Cancers with KRAS p.G12C Mutation.
N Engl J Med
; 384(25): 2371-2381, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096690
5.
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.
Br J Cancer
; 129(5): 797-810, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474720
6.
Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib.
Oncologist
; 28(4): 287-296, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892150
7.
Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-ß, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial.
Oncologist
; 28(2): e124-e127, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576431
8.
Adagrasib: a novel inhibitor for KRASG12C-mutated non-small-cell lung cancer.
Future Oncol
; 19(15): 1037-1051, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133216
9.
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab.
Future Oncol
; 19(33): 2213-2225, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589131
10.
Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial.
Lancet Oncol
; 23(10): 1261-1273, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108661
11.
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors.
Invest New Drugs
; 40(3): 596-605, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150356
12.
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer.
Future Oncol
; 18(6): 639-647, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911336
13.
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2027-2039, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280657
14.
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
Invest New Drugs
; 39(5): 1348-1356, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830407
15.
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).
Proc Natl Acad Sci U S A
; 115(43): E10119-E10126, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297397
16.
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
Cancer
; 126(2): 432-443, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31581306
17.
Adagrasib in Non-Small-Cell Lung Cancer. Reply.
N Engl J Med
; 387(13): 1238-1239, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170509
18.
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
JAMA
; 323(13): 1266-1276, 2020 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259228
19.
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer.
Br J Cancer
; 121(3): 211-217, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231122
20.
A review of canakinumab and its therapeutic potential for non-small cell lung cancer.
Anticancer Drugs
; 30(9): 879-885, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31503012